Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Green Karat is an Israeli medical cannabis company specializing in the cultivation and production of premium, indoor-grown cannabis flowers. The company utilizes advanced hydroponic systems and strictly controlled environmental conditions to ensure high-potency and consistent chemical profiles for medical patients. Green Karat focuses on the craft segment of the market, emphasizing pharmaceutical-grade quality to meet the rigorous standards of the Israeli Ministry of Health. Their product portfolio is recognized for high THC concentrations and specific terpene profiles tailored for therapeutic efficacy in pain management and neurology. The company also engages in international exports, particularly to the European market, adhering to EU-GMP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Karat.